303 related articles for article (PubMed ID: 35487591)
1. Sciatic nerve injury rebalances the hypothalamic-pituitary-adrenal axis in rats with persistent changes to their social behaviours.
Sosa MK; Boorman DC; Keay KA
J Neuroendocrinol; 2022 Jun; 34(6):e13131. PubMed ID: 35487591
[TBL] [Abstract][Full Text] [Related]
2. The impact of sciatic nerve injury and social interactions testing on glucocorticoid receptor expression in catecholaminergic medullary cell populations.
Sosa MKS; Boorman DC; Keay KA
Brain Res; 2023 Nov; 1819():148542. PubMed ID: 37604315
[TBL] [Abstract][Full Text] [Related]
3. Normal hypothalamo-pituitary-adrenal axis function in a rat model of peripheral neuropathic pain.
Bomholt SF; Mikkelsen JD; Blackburn-Munro G
Brain Res; 2005 May; 1044(2):216-26. PubMed ID: 15885220
[TBL] [Abstract][Full Text] [Related]
4. Limbic and HPA axis function in an animal model of chronic neuropathic pain.
Ulrich-Lai YM; Xie W; Meij JT; Dolgas CM; Yu L; Herman JP
Physiol Behav; 2006 Jun; 88(1-2):67-76. PubMed ID: 16647726
[TBL] [Abstract][Full Text] [Related]
5. Long-lasting deficient dexamethasone suppression of hypothalamic-pituitary-adrenocortical activation following peripheral CRF challenge in socially defeated rats.
Buwalda B; de Boer SF; Schmidt ED; Felszeghy K; Nyakas C; Sgoifo A; Van der Vegt BJ; Tilders FJ; Bohus B; Koolhaas JM
J Neuroendocrinol; 1999 Jul; 11(7):513-20. PubMed ID: 10444308
[TBL] [Abstract][Full Text] [Related]
6. Corticosterone, brain mineralocorticoid receptors (MRs) and the activity of the hypothalamic-pituitary-adrenal (HPA) axis: the Lewis rat as an example of increased central MR capacity and a hyporesponsive HPA axis.
Oitzl MS; van Haarst AD; Sutanto W; de Kloet ER
Psychoneuroendocrinology; 1995; 20(6):655-75. PubMed ID: 8584606
[TBL] [Abstract][Full Text] [Related]
7. Effect of repeated lipopolysaccharide administration on tissue cytokine expression and hypothalamic-pituitary-adrenal axis activity in rats.
Grinevich V; Ma XM; Herman JP; Jezova D; Akmayev I; Aguilera G
J Neuroendocrinol; 2001 Aug; 13(8):711-23. PubMed ID: 11489088
[TBL] [Abstract][Full Text] [Related]
8. Acute glucocorticoid pretreatment suppresses stress-induced hypothalamic-pituitary-adrenal axis hormone secretion and expression of corticotropin-releasing hormone hnRNA but does not affect c-fos mRNA or fos protein expression in the paraventricular nucleus of the hypothalamus.
Ginsberg AB; Campeau S; Day HE; Spencer RL
J Neuroendocrinol; 2003 Nov; 15(11):1075-83. PubMed ID: 14622438
[TBL] [Abstract][Full Text] [Related]
9. Hypothalamic-pituitary-adrenocortical axis changes in a transgenic mouse with impaired glucocorticoid receptor function.
Karanth S; Linthorst AC; Stalla GK; Barden N; Holsboer F; Reul JM
Endocrinology; 1997 Aug; 138(8):3476-85. PubMed ID: 9231802
[TBL] [Abstract][Full Text] [Related]
10. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
[TBL] [Abstract][Full Text] [Related]
11. Interaction between oestrogen and oxytocin on hypothalamic-pituitary-adrenal axis activity.
Ochedalski T; Subburaju S; Wynn PC; Aguilera G
J Neuroendocrinol; 2007 Mar; 19(3):189-97. PubMed ID: 17280592
[TBL] [Abstract][Full Text] [Related]
12. Differential and age-dependent effects of maternal deprivation on the hypothalamic-pituitary-adrenal axis of brown norway rats from youth to senescence.
Workel JO; Oitzl MS; Fluttert M; Lesscher H; Karssen A; de Kloet ER
J Neuroendocrinol; 2001 Jul; 13(7):569-80. PubMed ID: 11442771
[TBL] [Abstract][Full Text] [Related]
13. Aging is associated in the 344/N Fischer rat with decreased stress responsivity of central and peripheral catecholaminergic systems and impairment of the hypothalamic-pituitary-adrenal axis.
Cizza G; Gold PW; Chrousos GP
Ann N Y Acad Sci; 1995 Dec; 771():491-511. PubMed ID: 8597425
[TBL] [Abstract][Full Text] [Related]
14. Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism.
Smith SM; Vaughan JM; Donaldson CJ; Rivier J; Li C; Chen A; Vale WW
Endocrinology; 2004 Nov; 145(11):5202-9. PubMed ID: 15271883
[TBL] [Abstract][Full Text] [Related]
15. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
[TBL] [Abstract][Full Text] [Related]
16. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
Zhou Y; Spangler R; Schlussman SD; Ho A; Kreek MJ
Brain Res; 2003 Feb; 964(2):187-99. PubMed ID: 12576179
[TBL] [Abstract][Full Text] [Related]
17. Differential responsivity of the hypothalamic-pituitary-adrenal axis to glucocorticoid negative-feedback and corticotropin releasing hormone in rats undergoing morphine withdrawal: possible mechanisms involved in facilitated and attenuated stress responses.
Houshyar H; Galigniana MD; Pratt WB; Woods JH
J Neuroendocrinol; 2001 Oct; 13(10):875-86. PubMed ID: 11679056
[TBL] [Abstract][Full Text] [Related]
18. Effects of prenatal ethanol exposure on basal limbic-hypothalamic-pituitary-adrenal regulation: role of corticosterone.
Glavas MM; Ellis L; Yu WK; Weinberg J
Alcohol Clin Exp Res; 2007 Sep; 31(9):1598-610. PubMed ID: 17760789
[TBL] [Abstract][Full Text] [Related]
19. Regulatory mechanism of hypothalamo-pituitary-adrenal (HPA) axis and neuronal changes after adrenalectomy in type 2 diabetes.
Yi SS; Hwang IK; Shin JH; Choi JH; Lee CH; Kim IY; Kim YN; Won MH; Park IS; Seong JK; Yoon YS
J Chem Neuroanat; 2010 Oct; 40(2):130-9. PubMed ID: 20472052
[TBL] [Abstract][Full Text] [Related]
20. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. II. Biochemical and physiological evidence for the development of tolerance after chronic administration.
Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
J Pharmacol Exp Ther; 1991 Feb; 256(2):795-800. PubMed ID: 1847213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
